SECOR Capital Advisors, LP - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 96 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SECOR Capital Advisors, LP ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$566,000
+528.9%
220,164
+461.4%
0.12%
+875.0%
Q4 2018$90,000
+69.8%
39,220
+163.9%
0.01%
+200.0%
Q1 2018$53,000
+55.9%
14,861
+38.8%
0.00%
-66.7%
Q2 2015$34,000
+3.0%
10,706
-37.9%
0.01%
-36.8%
Q3 2014$33,000
-89.4%
17,239
-84.2%
0.02%
-84.7%
Q4 2013$312,000109,4520.12%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Tamarack Advisers, LP 8,350,000$28,557,0005.86%
Ion Asset Management Ltd. 3,632,132$12,422,0001.43%
CM Management, LLC 500,000$1,710,0001.27%
SECTOR GAMMA AS 1,530,490$5,234,0000.96%
Rhenman & Partners Asset Management AB 1,520,000$5,198,0000.36%
Rock Springs Capital Management LP 4,742,000$16,218,0000.35%
Telemetry Investments, L.L.C. 90,000$308,0000.35%
DAFNA Capital Management LLC 275,500$942,0000.22%
KELLEHER FINANCIAL ADVISORS 100,000$342,0000.22%
Virtus ETF Advisers LLC 91,971$315,0000.13%
View complete list of RIGEL PHARMACEUTICALS INC shareholders